Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

The β3-adrenergic receptor is an exceptional member of the β-adrenergic receptor family. Recent findings suggest that it may play a more significant role in the cardiovascular system than previously recognized, partly through its potential anti-inflammatory actions. For this reason, it has been extensively studied as a potential target in cardiovascular therapy. In this review, we focus on the β3-adrenergic receptor agonists and their pharmacodynamics regarding receptor binding and activation. We then describe the mechanisms of action mediated by the β3-adrenergic receptor in blood vessels and in the heart under both physiological and pathological conditions. We particularly concentrate on the therapeutic potential in the arterial, pulmonary, and portal hypertension as well as cardiac arrhythmias, ischemia, and heart failure, considering both receptor agonism and antagonism.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2025-12-08
DOI
https://doi.org/10.3390/ijms262411844
Citations
1
Primary Topic
Adipose Tissue and Metabolism
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

Małgorzata Wojciechowska, Anna Porębska, Marcin Mateusz Granat, Marcel Kempiński et al.
1 citations
International Journal of Molecular Sciences
Adipose Tissue and Metabolism
1.16
article

Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

Małgorzata Wojciechowska, Anna Porębska, Marcin Mateusz Granat, Marcel Kempiński, Paweł Jańczak, Patrycja Sandra Zawadzka, Paulina Jastrzębska
article en
1 citations

Abstract

The β3-adrenergic receptor is an exceptional member of the β-adrenergic receptor family. Recent findings suggest that it may play a more significant role in the cardiovascular system than previously recognized, partly through its potential anti-inflammatory actions. For this reason, it has been extensively studied as a potential target in cardiovascular therapy. In this review, we focus on the β3-adrenergic receptor agonists and their pharmacodynamics regarding receptor binding and activation. We then describe the mechanisms of action mediated by the β3-adrenergic receptor in blood vessels and in the heart under both physiological and pathological conditions. We particularly concentrate on the therapeutic potential in the arterial, pulmonary, and portal hypertension as well as cardiac arrhythmias, ischemia, and heart failure, considering both receptor agonism and antagonism.

International Journal of Molecular SciencesVol. 26(24)
Medical University of Warsaw (PL)
Openalex Percentile: Top 16%
Adipose Tissue and Metabolism
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.